Casandra
Casandra Test Code QD49186Version 1 (DRAFT)
Performing Lab
Drug Monitoring, Benzodiazepines, with Confirmation, Urine
Also known as: Prescription Drug Monitoring, Pain Management
Clinical Use
Order TestUse
This test provides initial screening for benzodiazepines in urine specimens. If the screen is positive, confirmatory testing is performed on specific benzodiazepine metabolites, enabling definitive identification of individual compounds.
Special Instructions
Not provided.
Limitations
Not provided.
Test Details
Methodology
Mass Spectrometry
Biomarkers
2 components
Benzodiazepine ScreenBenzodiazepine Confirmation
Result Turnaround Time
Not provided.
Related Documents
For more information, please review the documents below
Specimen Requirements
Specimen
Urine
Volume
20 mL
Minimum Volume
7 mL
Container
Clinical drug test transport vial
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 14 days |
| Refrigerated | 14 days |
Related Tests
Other tests from different labs that may be relevant
Benzodiazepine Confirmation, Urine
Mayo Clinic Lab
Benzodiazepines, Urine Screen with Reflex to Quantitation
ARUP Laboratories
Benzodiazepines, Urine, Quantitative
ARUP Laboratories
Benzodiazepines, Screen and Confirmation, Urine (Pain Management)
Labcorp
Benzodiazepine and Metabolite Confirmation (Labcorp MedWatch®)
Labcorp
Benzodiazepines Confirmation, Random, Urine
Mayo Clinic Lab
Targeted Benzodiazepine Screen, Random, Urine
Mayo Clinic Lab
Benzodiazepines Confirmation, Chain of Custody, Random, Urine
Mayo Clinic Lab
Designer Benzodiazepines, Screen With Confirmation, Urine Clinical
Labcorp
Benzodiazepines, Screen Only, Urine
Labcorp